FIELD: medicine, pediatrics. SUBSTANCE: agent has the following components, %: ferbitol, 40-60; sodium fumarate, 8-10; sugar syrup 20-30; and water for injection, up to 1 l. EFFECT: enhanced effectiveness of agent. 2 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT FOR ASIDEROTIC ANEMIA TREATMENT | 1994 |
|
RU2098101C1 |
TRIVALENT IRON FUMARATE HYDRATE AS AGENT FOR TREATING IRON-DEFICIENT ANEMIA PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 1997 |
|
RU2161963C2 |
ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
MEDICINAL AGENT FOR TREATMENT OF ASIDEROTIC ANEMIA | 2005 |
|
RU2280457C1 |
METHOD FOR TREATING IRON DEFICIENCY ANEMIA IN CHILDREN | 1993 |
|
RU2101043C1 |
PHARMACOLOGICAL COMPOSITION FOR IRON DEFICIENCY ANEMIA TREATMENT | 2021 |
|
RU2763135C1 |
METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
PHARMACOLOGICAL COMPOSITION ON BASIS OF IRON COMPOUNDS | 2016 |
|
RU2625739C1 |
METHOD OF PREPARING THE PRESERVING AGENT FOR ERYTHROCYTES | 1995 |
|
RU2098959C1 |
Authors
Dates
1997-12-10—Published
1994-09-26—Filed